90NORTH’s Adriano Botter explores natural language processing’s role in transforming the pharmaceutical industry

In the latest from Pharma Live, Adriano Botter, Executive Product Director at 90NORTH, shares his perspective on how natural language processing (NLP), a facet of AI, can impact the pharmaceutical industry. 

He explains that NLP “can make sense of the vast amount of unstructured data,” allowing for a detailed understanding of behaviors and preferences that pharmacuetical companies can then use to inform their strategy. 

“Through its lens, pharmaceutical companies gain a comprehensive and objective view of factors affecting health outcomes, transcending traditional boundaries,” Adriano said. “This approach incorporates patient decision, engagement, adherence behaviors, and socio-economic factors to improve treatment results.”